NGNE
Price
$39.66
Change
-$0.34 (-0.85%)
Updated
Nov 13 closing price
ZNTL
Price
$3.92
Change
+$0.21 (+5.66%)
Updated
Nov 13 closing price
104 days until earnings call
Ad is loading...

NGNE vs ZNTL

Header iconNGNE vs ZNTL Comparison
Open Charts NGNE vs ZNTLBanner chart's image
Neurogene
Price$39.66
Change-$0.34 (-0.85%)
Volume$589.65K
CapitalizationN/A
Zentalis Pharmaceuticals
Price$3.92
Change+$0.21 (+5.66%)
Volume$2.23M
CapitalizationN/A
NGNE vs ZNTL Comparison Chart
Loading...
NGNE
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
ZNTL
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
NGNE vs. ZNTL commentary
Nov 14, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NGNE is a Sell and ZNTL is a Buy.

COMPARISON
Comparison
Nov 14, 2024
Stock price -- (NGNE: $39.54 vs. ZNTL: $3.91)
Brand notoriety: NGNE and ZNTL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NGNE: 283% vs. ZNTL: 91%
Market capitalization -- NGNE: $513.77M vs. ZNTL: $278.03M
NGNE [@Biotechnology] is valued at $513.77M. ZNTL’s [@Biotechnology] market capitalization is $278.03M. The market cap for tickers in the [@Biotechnology] industry ranges from $473.6B to $0. The average market capitalization across the [@Biotechnology] industry is $2.76B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NGNE’s FA Score shows that 0 FA rating(s) are green whileZNTL’s FA Score has 1 green FA rating(s).

  • NGNE’s FA Score: 0 green, 5 red.
  • ZNTL’s FA Score: 1 green, 4 red.
According to our system of comparison, both NGNE and ZNTL are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NGNE’s TA Score shows that 2 TA indicator(s) are bullish while ZNTL’s TA Score has 5 bullish TA indicator(s).

  • NGNE’s TA Score: 2 bullish, 7 bearish.
  • ZNTL’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, ZNTL is a better buy in the short-term than NGNE.

Price Growth

NGNE (@Biotechnology) experienced а -38.13% price change this week, while ZNTL (@Biotechnology) price change was +1.82% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.97%. For the same industry, the average monthly price growth was +5.49%, and the average quarterly price growth was +6.49%.

Reported Earning Dates

NGNE is expected to report earnings on Nov 14, 2023.

ZNTL is expected to report earnings on Feb 26, 2025.

Industries' Descriptions

@Biotechnology (-1.97% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NGNE($514M) has a higher market cap than ZNTL($278M). NGNE YTD gains are higher at: 104.025 vs. ZNTL (-74.191). NGNE has higher annual earnings (EBITDA): -44.3M vs. ZNTL (-219.22M). NGNE has more cash in the bank: 111M vs. ZNTL (37M). NGNE has less debt than ZNTL: NGNE (15.9M) vs ZNTL (41.3M). ZNTL has higher revenues than NGNE: ZNTL (40.6M) vs NGNE (925K).
NGNEZNTLNGNE / ZNTL
Capitalization514M278M185%
EBITDA-44.3M-219.22M20%
Gain YTD104.025-74.191-140%
P/E RatioN/AN/A-
Revenue925K40.6M2%
Total Cash111M37M300%
Total Debt15.9M41.3M38%
FUNDAMENTALS RATINGS
NGNE: Fundamental Ratings
NGNE
OUTLOOK RATING
1..100
64
VALUATION
overvalued / fair valued / undervalued
1..100
76
Overvalued
PROFIT vs RISK RATING
1..100
60
SMR RATING
1..100
93
PRICE GROWTH RATING
1..100
40
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
20

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
NGNEZNTL
RSI
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 1 day ago
88%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
89%
Momentum
ODDS (%)
Bearish Trend 1 day ago
88%
Bullish Trend 1 day ago
79%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
79%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
87%
Bullish Trend 1 day ago
83%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
85%
Bullish Trend 1 day ago
81%
Advances
ODDS (%)
Bullish Trend 11 days ago
85%
Bullish Trend 4 days ago
84%
Declines
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 21 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
80%
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Ad is loading...
NGNE
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
ZNTL
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MNDFX9.28N/A
N/A
Manning & Napier Disciplined Value I
FCVSX36.73-0.09
-0.24%
Fidelity Convertible Securities
AWSYX17.09-0.05
-0.29%
Invesco Global Core Equity Y
FCGPX20.86-0.08
-0.38%
NYLI PineStone Global Equity Class P
FDGKX39.60-0.27
-0.68%
Fidelity Dividend Growth K

NGNE and

Correlation & Price change

A.I.dvisor indicates that over the last year, NGNE has been loosely correlated with BRNS. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if NGNE jumps, then BRNS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NGNE
1D Price
Change %
NGNE100%
-1.15%
BRNS - NGNE
51%
Loosely correlated
+0.04%
RNAZ - NGNE
48%
Loosely correlated
-6.18%
ZNTL - NGNE
39%
Loosely correlated
+5.39%
BPTSY - NGNE
38%
Loosely correlated
N/A
NKTX - NGNE
33%
Poorly correlated
-4.59%
More

ZNTL and

Correlation & Price change

A.I.dvisor indicates that over the last year, ZNTL has been loosely correlated with MDGL. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if ZNTL jumps, then MDGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ZNTL
1D Price
Change %
ZNTL100%
+5.39%
MDGL - ZNTL
51%
Loosely correlated
-7.05%
ORMP - ZNTL
43%
Loosely correlated
-0.64%
NRIX - ZNTL
40%
Loosely correlated
+0.52%
VCYT - ZNTL
39%
Loosely correlated
+3.37%
SRPT - ZNTL
38%
Loosely correlated
-1.61%
More